Log in to save to my catalogue

OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer

OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2648625796

OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer

About this item

Full title

OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer

Publisher

England: BMJ Publishing Group Ltd and British Society of Gastroenterology

Journal title

Gut, 2022-05, Vol.71 (5), p.1043-1044

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd and British Society of Gastroenterology

More information

Scope and Contents

Contents

Correspondence to Dr Yoku Hayakawa, Department of Gastroenterology, Graduate school of medicine, the University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan; yhayakawa-tky@umin.ac.jp ; Dr Ryota Niikura, Department of Gastroenterology, Graduate school of medicine, the University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan; niikura-dky@umi...

Alternative Titles

Full title

OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2648625796

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2648625796

Other Identifiers

ISSN

0017-5749

E-ISSN

1468-3288

DOI

10.1136/gutjnl-2021-325551

How to access this item